GE Healthcare and BAC start collaboration in biopharmaceutical purification
24 Oct 2006 -
GE Healthcare and BAC BV announced that they have entered into a strategic collaboration in the affinity ligand and chromatographic media area. Under the terms of the agreement, the two companies plant to develop new affinity chromatography media for human antibodies and adeno-associated virus (AAV) viral vector purification. The first products are expected to be commercially available during 2007
through GE Healthcare's Custom Designed Media business. The collaboration is expected to generate several new innovative affinity chromatography media solutions for biopharmaceutical manufacture and drug discovery research.
Additional information
BAC B.V. (Biotechnology Application Centre B.V.) Naarden, Netherlands
Top
Contact
Print version
Send article
RSS feed